机译:基于抗体的三阴性乳腺癌治疗研究进展
Sch Publ Hlth,Xiamen Univ;
Brown Fdn Inst Mol Med,Univ Texas Hlth Sci Ctr Houston;
TNBC; antibody; immune checkpoint inhibitor; antibody-drug conjugate; CAR-T; TUMOR-INFILTRATING LYMPHOCYTES; PHASE-III TRIAL; CAR T-CELLS; DOUBLE-BLIND; SACITUZUMAB GOVITECAN; 1ST-LINE TREATMENT; WEEKLY PACLITAXEL; PLUS BEVACIZUMAB; DRUG CONJUGATE; OPEN-LABEL;